drugset / Trial / NCT03467984
A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of LBVE (Multivalent Pneumococcal Conjugate Vaccine) in healthy infants.
Timeline
- Start
- 2018-05-25
- Primary completion
- 2018-10-05
- Completion
- 2019-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LBVE | Unknown | 0.5 ml | Intramuscular |
| Comparator | Prevnar 13 | Vaccine | 0.5 ml | Intramuscular |